These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10430835)

  • 1. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.
    Meguro K; Blaizot X; Kondoh Y; Le Mestric C; Baron JC; Chavoix C
    Brain; 1999 Aug; 122 ( Pt 8)():1519-31. PubMed ID: 10430835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between visual recognition memory and neocortical and hippocampal glucose metabolism after bilateral rhinal cortex lesions in the baboon: implications for Alzheimer's disease.
    Blaizot X; Meguro K; Millien I; Baron JC; Chavoix C
    J Neurosci; 2002 Nov; 22(21):9166-70. PubMed ID: 12417640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain glucose hypometabolism after perirhinal lesions in baboons: implications for Alzheimer disease and aging.
    Millien I; Blaizot X; Giffard C; Mézenge F; Insausti R; Baron JC; Chavoix C
    J Cereb Blood Flow Metab; 2002 Oct; 22(10):1248-61. PubMed ID: 12368664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.
    Meguro K; LeMestric C; Landeau B; Desgranges B; Eustache F; Baron JC
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):315-21. PubMed ID: 11511703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion.
    Le Mestric C; Chavoix C; Chapon F; Mézenge F; Epelbaum J; Baron JC
    J Cereb Blood Flow Metab; 1998 May; 18(5):476-90. PubMed ID: 9591840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization.
    Desgranges B; Baron JC; de la Sayette V; Petit-Taboué MC; Benali K; Landeau B; Lechevalier B; Eustache F
    Brain; 1998 Apr; 121 ( Pt 4)():611-31. PubMed ID: 9577389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral glucose metabolism in unilateral entorhinal cortex-lesioned rats: an animal PET study.
    Hayashi T; Fukuyama H; Katsumi Y; Hanakawa T; Nagahama Y; Yamauchi H; Tsukada H; Shibasaki H
    Neuroreport; 1999 Jul; 10(10):2113-8. PubMed ID: 10424684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.
    Yakushev I; Schreckenberger M; Müller MJ; Schermuly I; Cumming P; Stoeter P; Gerhard A; Fellgiebel A
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2219-27. PubMed ID: 21792570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous.
    Josephs KA; Tosakulwong N; Graff-Radford J; Weigand SD; Buciuc M; Machulda MM; Jones DT; Schwarz CG; Senjem ML; Ertekin-Taner N; Kantarci K; Boeve BF; Knopman DS; Jack CR; Petersen RC; Lowe VJ; Whitwell JL
    Ann Clin Transl Neurol; 2020 May; 7(5):707-721. PubMed ID: 32293805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater metabolic rate decreases in hippocampal formation and proisocortex than in neocortex in Alzheimer's disease.
    Stein DJ; Buchsbaum MS; Hof PR; Siegel BV; Shihabuddin L
    Neuropsychobiology; 1998; 37(1):10-9. PubMed ID: 9438267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
    Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
    Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.
    Mosconi L; Pupi A; De Cristofaro MT; Fayyaz M; Sorbi S; Herholz K
    J Nucl Med; 2004 Mar; 45(3):382-92. PubMed ID: 15001677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
    Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
    Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.
    Fukumitsu N; Ishii K; Kimura Y; Oda K; Hashimoto M; Suzuki M; Ishiwata K
    Ann Nucl Med; 2008 Dec; 22(10):841-7. PubMed ID: 19142702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.
    Villain N; Desgranges B; Viader F; de la Sayette V; Mézenge F; Landeau B; Baron JC; Eustache F; Chételat G
    J Neurosci; 2008 Jun; 28(24):6174-81. PubMed ID: 18550759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.